Open Access

ARTICLE

Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer

SUNG HEE LIM^1,#, HEE JIN CHO^1,2,3,#, KYOUNG-MEE KIM⁴, HO YEONG LIM¹, WON KI KANG¹, JEEYUN LEE¹, YOUNG SUK PARK¹, HEE CHEOL KIM^5,*, SEUNG TAE KIM^1,*

1 Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, 06351, Korea
2 Precision Medicine Research Institute, Samsung Medical Center, Gangnam-gu, Seoul, 06351, Korea
3 Department of Biomedical Convergence Science and Technology, Kyungpook National University, Daegu, 41566, Korea
4 Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Korea
5 Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, 06351, Korea

* Corresponding Authors: HEE CHEOL KIM. Email: ; SEUNG TAE KIM. Email:
# These authors contributed equally to this work